Sp636
PANEL DISCUSSION: IMMUNISATION AND SUSCEPTIBILITY TO INFECTION IN PATIENTS WITH IBD
Date
May 7, 2023
Explore related products in the following collection:
Society: AGA
The Cochrane Gut group supports the production of high quality and methodologically rigorous reviews for a portfolio that includes upper GI, IBD and functional bowel disease topics in adults and children. In this session, three themes will be discussed that are very relevant to IBD care in a world recovering from and living with COVID. We will discuss immunization and susceptibility to infection in IBD patients. We will consider remote telehealth and patient education to support distance and patient directed care, Finally, we will consider Long-COVID in IBD. Each presentation will consider evidence synthesis in the form of Cochrane and none Cochrane reviews, as well as critically appraising the literature in a manner that supports transparency and clinical utility of findings. After each presentation, our panel of speakers and the moderators will discuss the relevance of the findings in relation to current practice and guidance and explore where gaps exist.
The Cochrane Gut group supports the production of high quality and methodologically rigorous reviews for a portfolio that includes upper GI, IBD and functional bowel disease topics in adults and children. In this session, three themes will be discussed that are very relevant to IBD care in a world recovering from and living with COVID. We will discuss immunization and susceptibility to infection in IBD patients. We will consider remote telehealth and patient education to support distance and patient directed care, Finally, we will consider Long-COVID in IBD. Each presentation will consider evidence synthesis in the form of Cochrane and none Cochrane reviews, as well as critically appraising the literature in a manner that supports transparency and clinical utility of findings. After each presentation, our panel of speakers and the moderators will discuss the relevance of the findings in relation to current practice and guidance and explore where gaps exist.
Tracks
Related Products
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
IMMUNISATION AND SUSCEPTIBILITY TO INFECTION IN PATIENTS WITH IBD
The Cochrane Gut group supports the production of high quality and methodologically rigorous reviews for a portfolio that includes upper GI, IBD and functional bowel disease topics in adults and children…
TEMPORAL TRENDS AND RELATIVE RISKS OF INTESTINAL AND EXTRA-INTESTINAL CANCERS IN PERSONS WITH INFLAMMATORY BOWEL DISEASES: A POPULATION-BASED STUDY FROM A LARGE CANADIAN PROVINCE
BACKGROUND: Cancer is a major cause of morbidity and mortality in persons with inflammatory bowel disease (IBD). We evaluated temporal trends and relative risks of intestinal and extra-intestinal cancers among persons with IBD and matched controls…
LONG-TERM OUTCOMES AND COMPLICATIONS OF COVID IN IBD PATIENTS
The Cochrane Gut group supports the production of high quality and methodologically rigorous reviews for a portfolio that includes upper GI, IBD and functional bowel disease topics in adults and children…
